# Infleqtion, Inc.: financial statements, quarterly

INFQ · NYSE · CIK 2007825 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/infq.md) · [Financials](/companies/infq/financials.md) · [Filings](/companies/infq/filings.md) · [Insiders](/companies/infq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/infq/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | [8.3](/filings/0001193125-26-227206.md) | [5.3](/filings/0001628280-26-057508.md) | [7.3 d](/filings/0001628280-26-057508.md) | [10.3 d](/filings/0001628280-26-057508.md) | [9.9](/filings/0001628280-26-057508.md) | [13.5](/filings/0001628280-26-057508.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | [4.9](/filings/0001193125-26-227206.md) | [4.6](/filings/0001628280-26-057508.md) | [3.6 d](/filings/0001628280-26-057508.md) | [6.9 d](/filings/0001628280-26-057508.md) | [7.4](/filings/0001628280-26-057508.md) | [11.4](/filings/0001628280-26-057508.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | [3.4](/filings/0001193125-26-227206.md) | [0.7](/filings/0001628280-26-057508.md) | [3.7 d](/filings/0001628280-26-057508.md) | [3.5 d](/filings/0001628280-26-057508.md) | [2.5](/filings/0001628280-26-057508.md) | [2.2](/filings/0001628280-26-057508.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | [5.2](/filings/0001193125-26-227206.md) | [5.3](/filings/0001628280-26-057508.md) | not reported | not reported | [10.0](/filings/0001193125-26-227206.md) | [12.7](/filings/0001628280-26-057508.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | [5.8](/filings/0001193125-26-227206.md) | [6.3](/filings/0001628280-26-057508.md) | not reported | not reported | [26.3](/filings/0001193125-26-227206.md) | [19.8](/filings/0001628280-26-057508.md) |
| Operating income | $m | [(0.0)](/filings/0001193125-25-140724.md) | [(0.0)](/filings/0001193125-25-179808.md) | [(0.0)](/filings/0001193125-25-277719.md) | [(54.9) d](/filings/0001628280-26-057508.md) | [(7.0)](/filings/0001193125-26-227206.md) | [(10.4)](/filings/0001628280-26-057508.md) | [(7.3)](/filings/0001193125-25-277719.md) | [(11.8) d](/filings/0001628280-26-057508.md) | [(33.0)](/filings/0001628280-26-057508.md) | [(29.9)](/filings/0001628280-26-057508.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-227206.md) | [0.0](/filings/0001628280-26-057508.md) | not reported | not reported | [0.0](/filings/0001193125-26-227206.md) | [0.0](/filings/0001628280-26-057508.md) |
| Net income | $m | [(0.0)](/filings/0001193125-25-277719.md) | [(0.0)](/filings/0001193125-25-277719.md) | [(0.0)](/filings/0001193125-25-277719.md) | [(55.7) d](/filings/0001628280-26-057508.md) | [(6.0)](/filings/0001193125-26-227206.md) | [(9.2)](/filings/0001628280-26-057508.md) | [(33.4)](/filings/0001193125-25-277719.md) | [(11.0) d](/filings/0001628280-26-057508.md) | [(29.7)](/filings/0001628280-26-057508.md) | [(24.7)](/filings/0001628280-26-057508.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001193125-25-140724.md) | not reported | not reported | not reported | [(0.41)](/filings/0001193125-26-227206.md) | [(0.59)](/filings/0001628280-26-057508.md) | not reported | not reported | [(0.25)](/filings/0001628280-26-057508.md) | [(0.11)](/filings/0001628280-26-057508.md) |
| Basic EPS | $ per share | [0.00](/filings/0001193125-25-140724.md) | not reported | not reported | not reported | [(0.41)](/filings/0001193125-26-227206.md) | [(0.59)](/filings/0001628280-26-057508.md) | not reported | not reported | [(0.25)](/filings/0001628280-26-057508.md) | [(0.11)](/filings/0001628280-26-057508.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-01-03) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-134544.md) | [0.0](/filings/0001193125-25-140724.md) | [1.2](/filings/0001193125-25-179808.md) | [1.1](/filings/0001193125-25-277719.md) | [11.7](/filings/0001628280-26-057508.md) | [84.7](/filings/0001193125-26-227206.md) | [59.3](/filings/0001628280-26-057508.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-134544.md) | not reported | [1.6](/filings/0001193125-25-179808.md) | [1.5](/filings/0001193125-25-277719.md) | [72.5](/filings/0001628280-26-057508.md) | [465](/filings/0001193125-26-227206.md) | [500](/filings/0001628280-26-057508.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [0.2](/filings/0001193125-26-134544.md) | [0.2](/filings/0001193125-25-140724.md) | [418](/filings/0001193125-25-179808.md) | [421](/filings/0001193125-25-277719.md) | [113](/filings/0001628280-26-057508.md) | [613](/filings/0001193125-26-227206.md) | [641](/filings/0001628280-26-057508.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [0.2](/filings/0001193125-26-134544.md) | [0.2](/filings/0001193125-25-140724.md) | [0.1](/filings/0001193125-25-179808.md) | [36.7](/filings/0001193125-25-277719.md) | [23.0](/filings/0001628280-26-057508.md) | [23.6](/filings/0001193125-26-227206.md) | [53.5](/filings/0001628280-26-057508.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [0.2](/filings/0001193125-26-134544.md) | not reported | [3.1](/filings/0001193125-25-179808.md) | [39.7](/filings/0001193125-25-277719.md) | [27.1](/filings/0001628280-26-057508.md) | [27.4](/filings/0001193125-26-227206.md) | [67.1](/filings/0001628280-26-057508.md) |
| Shareholders' equity | $m | [0.0](/filings/0001193125-26-134544.md) | [(0.0)](/filings/0001193125-25-277719.md) | [(0.0)](/filings/0001193125-25-277719.md) | [(0.0)](/filings/0001193125-25-277719.md) | [(185)](/filings/0001628280-26-057508.md) | [(189)](/filings/0001628280-26-057508.md) | [(197)](/filings/0001628280-26-057508.md) | [(38.0)](/filings/0001193125-25-277719.md) | [(211)](/filings/0001628280-26-057508.md) | [583](/filings/0001628280-26-057508.md) | [574](/filings/0001628280-26-057508.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.0](/filings/0001193125-25-140724.md) | [0.0 d](/filings/0001193125-25-179808.md) | [0.0 d](/filings/0001193125-25-277719.md) | [(0.0) d](/filings/0001628280-26-057508.md) | [(7.0)](/filings/0001193125-26-227206.md) | [(2.8) d](/filings/0001628280-26-057508.md) | [(6.2) d](/filings/0001628280-26-057508.md) | [(8.2) d](/filings/0001628280-26-057508.md) | [(19.2)](/filings/0001628280-26-057508.md) | [13.2 d](/filings/0001628280-26-057508.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2024-03-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.0](/filings/0001193125-25-140724.md) | [14.7](/filings/0001193125-26-227206.md) | [15.6](/filings/0001628280-26-057508.md) | [118](/filings/0001628280-26-057508.md) | [220](/filings/0001628280-26-057508.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 225,357,052 at 2026-08-14, from the cover of the [10-Q filed 2026-08-18](/filings/0001628280-26-057508.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.